Share
- Release Date: 15/11/12 16:38
- Summary: NTA: MLN: MLN NAV $0.8064 as at 13/11/12
- Price Sensitive: No
- Download Document 1.45KB
MLN
15/11/2012 14:38
NTA
REL: 1438 HRS Marlin Global Limited
NTA: MLN: MLN NAV $0.8064 as at 13/11/12
MLN NAV $0.8064 as at 13/11/12
Date 13/11/2012 6/11/2012
MLN NAV $0.8064 $0.8177
Share price close $0.66 $0.70
Discount 18% 14%
The above NAV is unaudited.
The net asset value per share is after deducting treasury stock (shares
acquired under the Marlin Global buyback programme).
The five largest portfolio holdings at 13 November 2012 are approximately as
follows:
Biotest (Germany) 6%
Sarin Technologies (Israel) 4%
Stratec Biomedical (Germany) 4%
Orthofix (United States) 4%
Wirecard (Germany) 4%
BACKGROUND
Marlin Global Limited ("Marlin") is a listed investment company that invests
in companies based outside of New Zealand and Australia. The investment
portfolio of Marlin is managed by Fisher Funds Management Limited, a
specialist fund manager with a track record of successful investing. Marlin
aims to offer investors competitive returns and access to a diversified
portfolio of investments through a single, investment vehicle. Marlin may
invest in listed international growth companies on any approved stock
exchange (excluding New Zealand or Australia) or unlisted international
companies not incorporated in New Zealand or Australia. The company listed on
the New Zealand Stock Exchange on 1 November 2007.
For further information please contact Marlin Global Limited, ph (09) 484
0365.
End CA:00229783 For:MLN Type:NTA Time:2012-11-15 14:38:20
